Objective-Calcific aortic valve disease (CAVD) is the most prevalent type of heart valve disease, affecting ≈2% of the US population. CAVD is characterized by the presence of calcific nodules, resulting in aortic valve (AoV) stenosis; however, the underlying mechanisms driving disease remain unknown. Studies of human diseased AoV provide initial evidence that bone morphogenetic protein (BMP) signaling, essential for normal bone formation, is activated during CAVD. Mice deficient in Klotho, an FGF23 transmembrane coreceptor, exhibit premature aging and develop AoV calcific nodules as occurs in human CAVD. The role of BMP signaling in the development of CAVD was examined in porcine aortic valve interstitial cells (VICs) and Klotho −/− mice. Approach and Results-We show that activation of BMP signaling, as indicated by pSmad1/5/8 expression, precedes and later localizes with AoV calcification in Klotho −/− mice. In addition, cellular and extracellular matrix changes resembling features of normal bone formation are accompanied by increased osteochondrogenic gene induction in calcified Klotho −/− AoV. Likewise, osteogenic media treatment of porcine VICs results in BMP pathway activation, increased osteochondrogenic gene induction, and formation of calcific nodules in vitro. We demonstrate that genetic inactivation of the BMP type IA receptor in Klotho −/− aortic VICs, as well as BMP pathway inhibition of osteogenic media-treated aortic VICs in vitro, results in the inhibition of AoV calcification. Conclusions-BMP signaling and osteochondrogenic gene induction are active in calcified Klotho −/− AoV in vivo and calcified porcine aortic VICs in vitro. Importantly, BMP signaling is required for the development of AoV calcification in vitro and in vivo. (S.J.C.). The online-only Data Supplement is available with this article at http://atvb.ahajournals.org/lookup/suppl/
C alcific aortic valve disease (CAVD) is a progressive disease, initially presenting with aortic valve (AoV) sclerosis, often leading to AoV stenosis and insufficiency later in life. The risk for developing CAVD increases with age, and CAVD is becoming more prevalent with increased average lifespan. 1 AoV stenosis affects 2.8% of individuals over the age of 75, and AoV regurgitation presents in ≈2% of the elderly. 2 To date, the only clinical therapy available to patients is AoV replacement surgery, which has significant limitations of coagulation and degeneration, and is often contraindicated in the elderly. [2] [3] [4] Thus, understanding the molecular mechanisms driving CAVD pathogenesis is crucial to the development of new therapeutic approaches.
Because of its association with aging, CAVD was believed to be a passive, degenerative disease. However, recent studies have demonstrated that CAVD is an active, cellular-driven process. 5 A hallmark in the progression of CAVD is AoV stenosis caused by extensive calcific deposits. 6 In adult healthy valves, resident valve interstitial cells (VICs) remain quiescent with fibroblast-like characteristics. Interestingly, in human CAVD, markers of endochondral bone formation-including Runx2, Alkaline Phosphatase, Osteopontin, and Osteocalcin-have been observed in VICs associated with areas of calcification, 7, 8 supporting activation of an osteoblast-like cell phenotype in CAVD. Bone morphogenetic protein (BMP) signaling is essential during heart valve development and in bone formation. 9, 10 Notably, studies of human CAVD revealed increased BMP2 and BMP4 ligand expression in calcified AoV, 11 as well as increased pSmad1/5/8, indicative of canonical BMP signaling, on the fibrosa side of AoV where most calcification occurs. 8, 12 Altogether these data demonstrate that osteochondrogenic markers and BMP signaling are active in human CAVD. However, the in vivo requirements of BMP signaling for osteochondrogenic gene induction and AoV calcification remain unknown.
The Klotho −/− mouse model, which exhibits premature aging associated with hyperphosphatemia, low vitamin D, and increased FGF23, has been used to study age-related diseases, including chronic kidney disease and vascular calcification. 13 Similar to human CAVD, Klotho −/− mice exhibit AoV calcification at the hinge region of the fibrosa side. 14 This is in contrast to hyperlipidemic mouse models of AoV disease, in which calcification occurs throughout the aorta and valve leaflet surface, accompanied by lipid accumulation and inflammation. 15, 16 Instead, calcification occurs independent of inflammation in Klotho −/− mice, making these mice useful for examination of molecular mechanisms of AoV calcification that are distinct from hyperlipidemia.
The goal of this study is to examine the requirements for BMP signaling during AoV calcification. Klotho −/− AoV exhibit features of endochondral bone formation and localized pSmad1/5/8 activation in the hinge region preceding calcific nodule formation. The ability of a small molecule inhibitor of BMP signaling to inhibit porcine aortic VIC calcification was tested in culture. Genetic inactivation of BMP type IA receptor (Bmpr1a) in aortic VICs of Klotho −/− mice was used to demonstrate the in vivo requirement for BMP signaling in the development of AoV calcification.
Materials and Methods
Materials and Methods are available in the online-only Data Supplement.
Results

Calcification of AoV in Klotho −/− Mice Exhibits Features of Endochondral Bone Formation
There is increasing evidence that the progression of human CAVD includes features of endochondral bone formation, including cartilage and bone-lineage gene induction. 8, 11 As demonstrated by Movat's pentachrome staining, which labels extracellular matrix (ECM) constituents of the Klotho −/− AoV, areas of cell condensation can be observed before calcification ( Figure 1B , 1E, and 1H). These condensed areas are associated with increased proteoglycans and the presence of chondrocyte-like cells as indicated by morphology ( Figure 1H ). Likewise, proteoglycan-rich areas are localized to calcific nodules surrounded by chondrocyte-like cells ( Figure 1C , 1F, and 1I). Thus, VICs localized to calcific nodules undergo cellular changes that resemble endochondral bone formation.
Analysis of gene expression of 6-week-old Klotho −/− AoV demonstrates a significant increase in mRNA levels of cartilage markers Sox9, Aggrecan, Col2a1, Col10a1, and Mef2c ( Figure 1J ), which are critical factors in chondrogenesis that precedes normal bone formation. In addition, osteogenic genes involved in bone mineralization, including Alkaline Phosphatase, Runx2, and Osteopontin, are also significantly increased in these AoV, compared with control Klotho +/+ AoV ( Figure 1J ). Together, these findings demonstrate that AoV calcification in the Klotho −/− mice is associated with increased cartilage and bone marker expression, supporting an endochondral bone-like process of calcification.
Calcific Nodules Are Populated by Endothelialand Neural Crest-Derived Cells in Klotho −/− Mice
Adult semilunar VICs include cells derived from endocardial cushion endothelial cells and neural crest of the developing embryo. 17 However, the contribution of each cell type to the areas of calcification and disease pathogenesis during adult CAVD remains unclear. The developmental origins of cells populating mature AoV leaflets were assessed using Tie2Cre labeling of endothelial-derived cells in comparison to Wnt1Cre lineage cells derived from embryonic neural crest. Tie2Cre and Wnt1Cre mice were crossed with ROSA26 mTmG mice to identify Cre-recombined cells found in the AoV. These Cre-positive cells are marked by membranetargeted green fluorescent protein compared with expression of membrane-targeted red fluorescence protein in cells that do not express Cre. 18 Endothelial-derived Tie2Cre-positive cells, indicated by green fluorescent protein, are distributed throughout all 3 leaflets in wild-type AoV ( Figure I Figure 3C and 3D), but BMP2 expression was not detected in controls ( Figure 3A and 3B ). In addition, BMP2 and BMP4 ligand gene expression is increased in Klotho −/− AoV compared with controls at 6 weeks ( Figure 3E ). Gene expression of the BMP pathway downstream target Smad6 also is significantly increased at 6 weeks ( Figure 3E ). Thus, active BMP pathway components are localized to areas of AoV calcification in Klotho −/− mice in vivo.
BMP Pathway Inhibition Prevents Calcific Nodule Formation and Osteochondrogenic Gene Induction in Aortic VICs Cultured In Vitro
As previously shown, 19 porcine VICs treated with osteogenic media (OM) form calcific nodules, as indicated by positive Alizarin Red ( Figure 4C ) and von Kossa ( Figure 4G ) staining after 9 days in culture. In contrast, VICs maintained in control media do not form calcific nodules ( Figure 4A ( Figure 5F ) and Osteocalcin ( Figure 5G ). However, BMP2 treatment alone in the absence of OM is not sufficient to promote calcification of aortic VICs in vitro ( Figure III in the online-only Data Supplement). Notably, treatment of porcine VICs for 9 days does not result in apoptosis ( Figure IV in the online-only Data Supplement). Together, these data demonstrate that BMP signaling is required, but is not sufficient, for the formation of calcific nodules and osteochondrogenic gene induction in cultured aortic VICs.
Genetic Inactivation of Bmpr1a Does Not Affect AoV Development or Maturation In Vivo
The requirement for BMP signaling in normal aortic VICs was examined in vivo using PostnCre;Bmpr1a flox/flox mice. PostnCre 22 is active in aortic VICs, but not in endothelial cells, and is expressed robustly throughout the AoV. 23 The Bmpr1a is required for BMP-mediated phosphorylation of Smad1/5/8 in many tissues, including heart valve progenitors. 24 Tie2Cre and Wnt1Cre are active in a subset of aortic VICs, and deletion of Bmpr1a in either of these lineages causes embryonic lethality. 25, 26 Therefore, the requirements for Bmpr1a in PostnCre lineage cells, present in embryonic and adult valves after endocardial cushion formation, were examined. Although BMP signaling plays essential roles during endocardial cushion EndMT, 24 PostnCre expression is observed in other regions outside of the AoV VICs, including fibroblasts located at the atrioventricular junction. 22 However, because PostnCre is activated after endocardial cushion formation, 23 Figure 6H ). However, inactivation of Bmpr1a in Klotho −/− AoV results in a significant decrease of AoV calcification, as evident by analysis of von Kossa staining, when compared with control mice that exhibit AoV calcification ( Figure 6A and 6D ). BMP pathway inactivation through loss of Bmpr1a also preserves normal ECM organization and cellular morphology ( Figure 6B and 6E) . Importantly, no pSmad1/5/8 immunoreactivity is observed in Klotho −/− ;PostnCre; Bmpr1a flox/flox AoV ( Figure 6F ). Total areas of calcification were measured and quantified for Klotho −/− ; PostnCre;Bmpr1a flox/flox and control Klotho −/− AoV von Kossa-stained images. Quantitative data show a significant decrease in the total calcified area of AoV in Klotho −/− ;PostnCre;Bmpr1a flox/flox mice when compared with Klotho −/− mice ( Figure 6G ). Together these data demonstrate the necessity of BMP-pSmad1/5/8 signaling for the development of AoV calcification in Klotho −/− mice.
Discussion
Here, we demonstrate that expression of pSmad1/5/8, indicative of active BMP signaling, precedes and later localizes with AoV calcification in Klotho −/− mice with CAVD. Likewise, BMP ligands BMP2 and BMP4 are significantly increased in Klotho −/− AoV. Consistent with previous studies, BMP signaling is required for osteogenic gene induction and calcification in cultured porcine VICs, similar to human VICs. 28-30 pSmad1/5/8 activation and increased BMP2 and BMP4 expression have been reported in human CAVD. 8, 11, 12 However, in vivo requirements for BMP signaling in AoV calcification have not been demonstrated previously. Here, we show that BMP pathway inhibition through genetic inactivation of Bmpr1a in Klotho −/− aortic VICs prevents AoV calcification in vivo. Thus, BMP signaling is required for CAVD.
BMP signaling has previously been implicated in valve development and disease. In developing valves, Bmpr1amediated BMP signaling is required for proper formation of the atrioventricular junction and endocardial cushions. 24, 26 Moreover, genetic deletion of the related receptor ALK2 (Acvr1) in the cushion mesenchyme leads to AoV defects, including bicuspid aortic valve. 31 In this study, we show that PostnCre-driven deletion of Bmpr1a after endocardial cushion formation does not affect valve development or adult homeostasis, but does inhibit AoV calcification in Klotho −/− mice. Interestingly, increased BMP signaling because of haploinsufficiency of the BMP inhibitor Smad6 is sufficient to promote aortic calcification. 32 Thus, BMP signaling has multiple critical roles in valve development and disease.
There is increasing evidence that AoV calcification during CAVD occurs via an endochondral bone formation-like process. 11 VICs derived from both endothelial and neural crest embryonic lineages are calcified, suggesting that the potential to calcify is associated with location within the valve, rather than a specific embryonic origin or cell lineage. Interestingly, BMP signaling via pSmad1/5/8 plays essential roles during endochondral bone formation by regulating expression of critical cartilage and bone factors. 33, 34 In accordance, osteochondrogenic gene induction, accompanied by cellular and ECM changes that resemble features of normal endochondral bone formation, occurs in calcified Klotho −/− AoV, where BMP signaling is active. Loss of BMP signaling through genetic deletion of Bmpr1a in vivo or inhibition of BMP receptor kinase activity by LDN-193189 in culture leads to loss of AoV osteochondrogenic characteristics and prevents formation of calcific nodules. Together these data demonstrate that BMP signaling is required for induction of endochondral bone formation-like processes during AoV calcification.
There are several risk factors associated with CAVD, including valve developmental defects, notably bicuspid aortic valve, inflammation because of increased lipid deposition, and hyperphosphatemia as a result of chronic kidney disease. Consequently, the underlying pathogenesis of CAVD may vary depending on the accompanying risk factors. 6, [35] [36] [37] Previous studies have shown that AoV calcification in Klotho −/− mice occurs independent of inflammation 14 or a myofibroblast intermediate. 19 Furthermore, Klotho −/− mice develop hyperphosphatemia secondary to chronic kidney disease and before the onset of AoV calcification along with other age-related phenotypes. 13, 27 The Klotho protein is a cofactor for fibroblast growth factor FGF23, and Klotho deficiency leads to abnormal mineral metabolism characterized by increased phosphate, calcium, and vitamin D serum levels. 38 Klotho deficiency also leads to increased Wnt signaling, 39, 40 which together with BMP signaling promotes endochondral bone formation and contributes to vascular calcification. 41 BMP signaling is not sufficient to induce AoV calcification, but the contributions of these additional factors in conjunction with increased BMP signaling to AoV pathogenesis remains to be elucidated.
CAVD is a progressive disease, and currently there are no pharmacological-based therapies that can prevent or inhibit CAVD. The current standard of treatment is AoV replacement, which is associated with significant complications that increase with age. 42 This study shows that BMP pathway inhibition prevents calcific nodule formation, a hallmark of CAVD pathology, demonstrating that BMP signaling is required for the development of CAVD. Importantly, in vitro treatment of porcine aortic VICs with BMP inhibitor LDN-193189 leads to inhibition of OM-induced calcific nodule formation. LDN-193189 is a small molecule inhibitor that specifically targets the BMP receptor Bmpr1a and has been shown to reduce soft tissue calcification, 21 as well as vascular calcification and atherosclerosis. 43, 44 However, LDN-193189 has not yet been tested in the context of CAVD. Our data demonstrates that targeting BMP signaling might serve as a new therapeutic approach in the prevention of AoV calcification during CAVD. 
